A new docetaxel (D) gemcitabine (G) regimen as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC): A phase II study
| Autor: | E. Brain, J. Mandet, P. Terrioux, K. Beerblock, Jean-François Morère, J. P. Duhamel, R. Fellague, Jeanne-Marie Bréchot, Mohamed Bouchahda, Jean Trédaniel |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Oncology
Cisplatin Cancer Research medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment Phases of clinical research non-small cell lung cancer (NSCLC) macromolecular substances medicine.disease Gemcitabine Regimen Docetaxel Internal medicine medicine First line chemotherapy business medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 23:7288-7288 |
| ISSN: | 1527-7755 0732-183X |
| Popis: | 7288 Background: Non containing cisplatin doublets could be an alternative chemotherapy in some NSCLC patients (pts). The optimal schedule of a DG regimen and the optimal duration of G infusion has... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|